Cynosure Lutronic Executive and Leadership Team

Nadav Tomer, the Chief Executive Officer at Cynosure Lutronic, directs the company's overall strategic vision and operational execution. Tomer guides the development and manufacturing of energy-based aesthetic and medical treatment systems, ensuring alignment with market demands for hair removal, skin revitalization, scar reduction, gynecological health, and body contouring solutions. This leadership role involves fostering innovation across research and development teams, driving global market penetration, and ensuring the company's position as a best-in-class creator of advanced treatment applications. By overseeing all facets of the business, Nadav Tomer ensures that practitioners, physicians, and aesthetic business owners worldwide receive cutting-edge technologies that enhance their service offerings and provide superior patient outcomes. The Chief Executive Officer's focus remains on expanding the company's technological leadership and solidifying its reputation for quality and efficacy in the competitive aesthetic industry.

Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure Lutronic, spearheads the strategic direction and operational management for Hoya Photonics Inc. Gehlmann's leadership ensures the integration of advanced photonics technologies with Cynosure's energy-based systems, driving innovation in medical and aesthetic treatment applications. This executive oversees the development of sophisticated optical components and systems critical for precise energy delivery in procedures such as hair removal, skin revitalization, and body contouring. Timothy Gehlmann's responsibilities include fostering cross-functional collaboration between Hoya Photonics and Cynosure's core business units, optimizing manufacturing processes, and expanding market reach for photonics-enabled solutions. The Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc ensures that Hoya Photonics Inc contributes significantly to Cynosure's mission of providing leading-edge medical and aesthetic treatment systems globally.

Cyriacus Njoku, the Chief Executive Officer & President at Cynosure Lutronic, drives the company's overarching strategic initiatives and operational performance. Njoku's executive oversight encompasses the full spectrum of Cynosure's product development, manufacturing, and global distribution of energy-based aesthetic and medical treatment systems. This leadership position involves cultivating a culture of innovation, ensuring the highest standards in product quality for applications like hair removal, skin revitalization, and body contouring. Cyriacus Njoku works to expand the company's market presence, forging key partnerships and ensuring that practitioners worldwide have access to state-of-the-art technologies. The Chief Executive Officer & President's focus is on enhancing the company's competitive edge and driving sustainable growth by delivering exceptional value to customers and patients through advanced medical and aesthetic solutions.

Robert Howe, the Chief Financial Officer at Cynosure Lutronic, directs all financial operations and strategic financial planning for the organization. Howe oversees budgeting, forecasting, financial reporting, and capital allocation to support the company's growth in developing and manufacturing energy-based aesthetic and medical treatment systems. This critical role involves managing financial risks, optimizing investment strategies, and ensuring the fiscal health necessary to drive innovation in areas such as hair removal, skin revitalization, and body contouring. Robert Howe collaborates closely with other executive leaders to align financial objectives with the company's mission of providing best-in-class treatment applications worldwide. The Chief Financial Officer's expertise is essential for maintaining financial stability, supporting research and development initiatives, and enabling the expansion of Cynosure's global reach to practitioners and physicians.

Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure Lutronic, provides comprehensive financial leadership and strategic fiscal management. Baker oversees the financial health of the organization, managing all aspects of accounting, financial planning, and analysis to support the development and manufacturing of advanced energy-based aesthetic and medical treatment systems. This executive role is integral to ensuring the company's financial stability and growth, particularly in expanding offerings for hair removal, skin revitalization, and body contouring. Baker Baker works to optimize resource allocation, manage investor relations, and implement financial controls that uphold the company's commitment to innovation and quality. The Executive Vice President & Chief Financial Officer's strategic insights are crucial for guiding investment decisions and supporting the global expansion of Cynosure's cutting-edge medical and aesthetic technologies.

Christopher Aronson, the President, North America at Cynosure Lutronic, leads the company's strategic initiatives and commercial operations across the United States and Canada. Aronson drives market penetration and revenue growth for Cynosure's diverse range of energy-based aesthetic and medical treatment systems, including solutions for hair removal, skin revitalization, and body contouring. This executive role involves overseeing sales, marketing, and customer support functions to ensure exceptional service and product adoption within the North American region. Christopher Aronson collaborates with global leadership to tailor strategies that meet the specific needs of practitioners, physicians, and aesthetic business owners in the region. The President, North America's leadership ensures that Cynosure remains a dominant force in delivering cutting-edge medical and aesthetic technologies to this key market.

Lowinn Kibbey, the President (North America) at Cynosure Lutronic, directs the strategic growth and operational execution for the North American market. Kibbey oversees the sales, marketing, and business development efforts for Cynosure's comprehensive portfolio of energy-based aesthetic and medical treatment systems, addressing needs in hair removal, skin revitalization, and body contouring. This leadership position involves fostering strong relationships with practitioners and physicians, driving market share, and ensuring the successful implementation of new treatment technologies. Lowinn Kibbey works to align regional objectives with the company's global mission, enhancing Cynosure's presence and impact across the United States and Canada. The President (North America)'s focus is on expanding access to innovative medical and aesthetic solutions and reinforcing Cynosure's commitment to excellence in the region.

Sean Flanagan, the Chief Legal Officer at Cynosure Lutronic, directs all legal affairs and ensures regulatory compliance across the company's global operations. Flanagan oversees the legal framework supporting the development, manufacturing, and distribution of energy-based aesthetic and medical treatment systems, including those for hair removal, skin revitalization, and body contouring. This executive role involves managing intellectual property, advising on corporate governance, and mitigating legal risks associated with product innovation and market expansion. Sean Flanagan collaborates with executive leadership to ensure all business practices adhere to international laws and industry standards, safeguarding the company's reputation and assets. The Chief Legal Officer's expertise is vital for navigating complex regulatory landscapes and supporting Cynosure's mission to provide safe and effective aesthetic and medical solutions worldwide.

Jae Yoo, the Chief Operations Officer at Cynosure Lutronic, oversees the company's global manufacturing, supply chain, and operational efficiency. Yoo directs the production processes for energy-based aesthetic and medical treatment systems, ensuring high-quality output for applications such as hair removal, skin revitalization, and body contouring. This leadership position involves optimizing operational workflows, managing inventory, and implementing strategies to enhance production capacity and reduce costs. Jae Yoo collaborates with engineering and R&D teams to streamline product development cycles and ensure seamless integration of new technologies into manufacturing. The Chief Operations Officer's focus is on maintaining operational excellence, supporting global distribution networks, and ensuring the reliable delivery of Cynosure's innovative medical and aesthetic solutions to practitioners worldwide.